Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Plos One|August 23, 2011
A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2Ebenezer Tumban, Julianne Peabody, David S Peabody, et al.
Biotechnology and Bioengineering|June 12, 2014
The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccineMitchell Tyler, Ebenezer Tumban, David S Peabody, et al.
Infection and Immunity|October 16, 2002
Activation of NKT cells protects mice from tuberculosisAlissa Chackerian, Jen Alt, Vaji Perera, et al.
Vaccine|September 3, 2021
A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in miceAlexandra Fowler, Maureen Sampson, Alan T Remaley, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
RNA Phage VLP-Based Vaccine PlatformsDavid S Peabody, Julianne Peabody, Steven B Bradfute, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
Determinants of autoantibody induction by conjugated papillomavirus virus-like particlesBryce Chackerian, Petra Lenz, Douglas R Lowy, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Virus-like particle (VLP)-based vaccine targeting tau phosphorylated at Ser396/Ser404 (PHF1) site outperforms phosphorylated S199/S202 (AT8) site in reducing tau pathology and restoring cognitive deficits in the rTg4510 mouse model of tauopathyJonathan Hulse, Nicole Maphis, Julianne Peabody, et al.
Journal of Virology|May 1, 1997
Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infectionB Chackerian, E M Long, P A Luciw, et al.
Research Square|July 1, 2024
Virus-like particle (VLP)-based vaccine targeting tau phosphorylated at Ser396/Ser404 (PHF1) site outperforms phosphorylated S199/S202 (AT8) site in reducing tau pathology and restoring cognitive deficits in the rTg4510 mouse model of tauopathyJonathan Hulse, Nicole Maphis, Julianne Peabody, et al.
Plos One|November 28, 2012
VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirusEbenezer Tumban, Julianne Peabody, Mitchell Tyler, et al.
Pageof 13